Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flibanserin Dosing in Premenopausal Women with HSDD
NCT00360555Phase 3Completed
- Sponsor
- Sprout Pharmaceuticals
- Start
- Jul 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of flibanserin in hypoactive sexual desire disorder (HSDD), sponsored by Sprout Pharmaceuticals. Started Jul 2006; status: completed.
02
Drugs
flibanserin
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT00360555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360555.